tradingkey.logo

vTv Therapeutics Inc <VTVT.OQ> expected to post a loss of 87 cents a share - Earnings Preview

ReutersMar 7, 2025 1:14 PM
  • vTv Therapeutics Inc VTVT.OQ VTVT.O is expected to show no change in quarterly revenue when it reports results on March 11 (estimated) for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for vTv Therapeutics Inc is for a loss of 87 cents per share.

  • The one available analyst rating on the shares is "buy".

  • The average consensus recommendation for the biotechnology & medical research peer group is also "Buy".​

  • Wall Street's median 12-month price target for vTv Therapeutics Inc is $35.00​, above​ its last closing price of $16.68. ​​​

This summary was machine generated March 7 at 13:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI